Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marianne Veyri

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Cancers|December 24, 2021
Kaposi's Sarcoma-Associated Herpesvirus, the Etiological Agent of All Epidemiological Forms of Kaposi's SarcomaAude Jary, Marianne Veyri, Adélie Gothland, et al.
Bulletin Du Cancer|January 26, 2020
[HIV and cancer: Update 2020]Baptiste Abbar, Marianne Veyri, Caroline Solas, et al.
JTO Clinical and Research Reports|November 26, 2021
Brief Report of Anti-Programmed Cell Death Protein-1 in Human Immunodeficiency Virus Setting: Relevant and Breaking Results in First-Line NSCLC TherapyLise Bertin, Anthony Canellas, Baptiste Abbar, et al.
Bulletin Du Cancer|August 28, 2021
Do people living with HIV face more secondary cancers than general population: From the French CANCERVIH networkMarianne Veyri, Armelle Lavolé, Sylvain Choquet, et al.
AIDS (London, England)|October 22, 2019
Immune checkpoint inhibitors in people living with HIV: what about anti-HIV effects?Baptiste Abbar, Marine Baron, Christine Katlama, et al.
Bulletin Du Cancer|March 18, 2018
[HIV and cancer : What's new in 2017?]Aurélien Gobert, Marianne Veyri, Isabelle Poizot-Martin, et al.
Cancers|February 25, 2022
Immune Reconstitution Inflammatory Syndrome Associated Kaposi SarcomaIsabelle Poizot-Martin, Sylvie Brégigeon, Romain Palich, et al.
Bulletin Du Cancer|March 14, 2021
[Survey on HIV, HBV and HCV screening practices in cancerology, France]Myriam Taouqi, Marianne Veyri, Sylvie Brégigeon, et al.
Cancers|February 15, 2022
Therapeutic Perspectives in the Systemic Treatment of Kaposi's SarcomaMarc-Antoine Valantin, Léna Royston, Maxime Hentzien, et al.
Scientific Reports|August 28, 2025
Impacts of immune checkpoint inhibitors use on the HIV reservoir are linked to provirus sequences but not integration sitesVincent Guiraud, Antoine Fauchois, Cathia Soulie, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Cancers|December 24, 2021
Kaposi's Sarcoma-Associated Herpesvirus, the Etiological Agent of All Epidemiological Forms of Kaposi's SarcomaAude Jary, Marianne Veyri, Adélie Gothland, et al.
Bulletin Du Cancer|January 26, 2020
[HIV and cancer: Update 2020]Baptiste Abbar, Marianne Veyri, Caroline Solas, et al.
JTO Clinical and Research Reports|November 26, 2021
Brief Report of Anti-Programmed Cell Death Protein-1 in Human Immunodeficiency Virus Setting: Relevant and Breaking Results in First-Line NSCLC TherapyLise Bertin, Anthony Canellas, Baptiste Abbar, et al.
Bulletin Du Cancer|August 28, 2021
Do people living with HIV face more secondary cancers than general population: From the French CANCERVIH networkMarianne Veyri, Armelle Lavolé, Sylvain Choquet, et al.
AIDS (London, England)|October 22, 2019
Immune checkpoint inhibitors in people living with HIV: what about anti-HIV effects?Baptiste Abbar, Marine Baron, Christine Katlama, et al.
Bulletin Du Cancer|March 18, 2018
[HIV and cancer : What's new in 2017?]Aurélien Gobert, Marianne Veyri, Isabelle Poizot-Martin, et al.
Cancers|February 25, 2022
Immune Reconstitution Inflammatory Syndrome Associated Kaposi SarcomaIsabelle Poizot-Martin, Sylvie Brégigeon, Romain Palich, et al.
Bulletin Du Cancer|March 14, 2021
[Survey on HIV, HBV and HCV screening practices in cancerology, France]Myriam Taouqi, Marianne Veyri, Sylvie Brégigeon, et al.
Cancers|February 15, 2022
Therapeutic Perspectives in the Systemic Treatment of Kaposi's SarcomaMarc-Antoine Valantin, Léna Royston, Maxime Hentzien, et al.
Scientific Reports|August 28, 2025
Impacts of immune checkpoint inhibitors use on the HIV reservoir are linked to provirus sequences but not integration sitesVincent Guiraud, Antoine Fauchois, Cathia Soulie, et al.
Pageof 3